Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycerophospholipid flippase activity	ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	8.60e-12	14	168	7	GO:0140333
GeneOntologyMolecularFunction	flippase activity	ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	4.77e-11	17	168	7	GO:0140327
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	5.72e-11	28	168	8	GO:0140326
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	3.83e-10	51	168	9	GO:0140303
GeneOntologyMolecularFunction	floppase activity	ATP8A2 ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.42e-09	16	168	6	GO:0140328
GeneOntologyMolecularFunction	phosphatidylserine floppase activity	ATP8A2 ATP8B1 ATP11B ATP11C ATP11A	4.87e-09	9	168	5	GO:0090556
GeneOntologyMolecularFunction	phosphatidylserine flippase activity	ATP8A2 ATP8B1 ATP11C ATP11A	2.40e-08	5	168	4	GO:0140346
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR2 RYR3 PKD2	7.16e-08	6	168	4	GO:0048763
GeneOntologyMolecularFunction	aminophospholipid flippase activity	ATP8A2 ATP8B1 ATP11C ATP11A	1.66e-07	7	168	4	GO:0015247
GeneOntologyMolecularFunction	phosphatidylethanolamine flippase activity	ATP8A2 ATP11B ATP11C ATP11A	1.66e-07	7	168	4	GO:0090555
GeneOntologyMolecularFunction	phospholipid transporter activity	ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	2.00e-07	74	168	8	GO:0005548
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR1 RYR2 RYR3 TPCN1 PKD2	3.11e-07	18	168	5	GO:0015278
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNA1C ATP13A4 PKD2L1 PKDREJ RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2	6.14e-07	151	168	10	GO:0015085
GeneOntologyMolecularFunction	lipid transporter activity	ATP8B4 APOA5 ATP8A2 ATP10B ATP8B1 SLCO1B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	8.69e-07	196	168	11	GO:0005319
GeneOntologyMolecularFunction	transporter activity	CACNA1C TPTE ATP6V1B2 ATP13A4 ATP8B4 TMEM120B TMC7 APOA5 ATP8A2 PKD2L1 ATP10B ATP8B1 NMUR2 SLC7A6 SLCO1B1 PKDREJ ATP8B2 RYR1 RYR2 RYR3 TPCN1 SLC12A3 PKD2L2 ATP11B SLC35B4 PKD2 ATP11C ATP11A ATG9A	1.09e-06	1289	168	29	GO:0005215
GeneOntologyMolecularFunction	calcium channel activity	CACNA1C PKD2L1 PKDREJ RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2	1.47e-06	129	168	9	GO:0005262
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2 RYR3	2.33e-06	4	168	3	GO:0005219
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	RYR1 RYR2 RYR3 TPCN1 PKD2	5.65e-06	31	168	5	GO:0099604
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	RYR1 RYR2 RYR3 TPCN1 PKD2	7.79e-06	33	168	5	GO:0005217
GeneOntologyMolecularFunction	phosphatidylcholine flippase activity	ATP10B ATP8B1 ATP8B2	1.15e-05	6	168	3	GO:0140345
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP13A4 ATP8B4 ATP8A2 SMC4 ATP10B BTAF1 ATP8B1 ATP8B2 ATP11B ATP11C ATP11A DNAH8 AQR DNAH11	2.28e-05	441	168	14	GO:0016887
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DENND5B OBSCN CHRM4 PREX2 RIN2 RAB3GAP2 SBF2 KIAA1755 PREX1 RAPGEFL1	2.70e-05	231	168	10	GO:0005085
GeneOntologyMolecularFunction	ATP-dependent activity	ATP6V1B2 ATP13A4 MYH11 ATP8B4 ATP8A2 SMC4 ATP10B BTAF1 ATP8B1 ATP8B2 ATP11B ATP11C ATP11A DNAH8 AQR DNAH11	6.43e-05	614	168	16	GO:0140657
GeneOntologyMolecularFunction	dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity	ALG10B ALG10	7.04e-05	2	168	2	GO:0106073
GeneOntologyMolecularFunction	monoatomic ion channel activity	CACNA1C TPTE TMEM120B TMC7 PKD2L1 NMUR2 PKDREJ RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2	1.42e-04	459	168	13	GO:0005216
GeneOntologyMolecularFunction	magnesium ion binding	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 REXO2 ATP11B ATP11C ATP11A	2.52e-04	247	168	9	GO:0000287
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	CACNA1C TPTE ATP6V1B2 ATP13A4 TMEM120B TMC7 PKD2L1 NMUR2 PKDREJ RYR1 RYR2 RYR3 TPCN1 SLC12A3 PKD2L2 ATP11B PKD2	3.89e-04	793	168	17	GO:0015075
GeneOntologyMolecularFunction	channel activity	CACNA1C TPTE TMEM120B TMC7 PKD2L1 NMUR2 PKDREJ RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2	5.15e-04	525	168	13	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	CACNA1C TPTE TMEM120B TMC7 PKD2L1 NMUR2 PKDREJ RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2	5.24e-04	526	168	13	GO:0022803
GeneOntologyMolecularFunction	phosphatidylcholine transporter activity	ATP10B ATP8B1 ATP8B2	6.00e-04	20	168	3	GO:0008525
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	PKD2L1 RYR1 RYR2 RYR3 TPCN1 PKD2	1.20e-03	140	168	6	GO:0099094
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	PKD2L1 NMUR2 RYR1 RYR2 RYR3 TPCN1 PKD2	1.26e-03	193	168	7	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	PKD2L1 NMUR2 RYR1 RYR2 RYR3 TPCN1 PKD2	1.42e-03	197	168	7	GO:0022834
GeneOntologyMolecularFunction	phosphatidylcholine floppase activity	ATP8B1 ATP8B2	1.91e-03	8	168	2	GO:0090554
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	CACNA1C ATP13A4 PKD2L1 PKDREJ RYR1 RYR2 RYR3 TPCN1 SLC12A3 PKD2L2 PKD2	1.98e-03	465	168	11	GO:0046873
GeneOntologyMolecularFunction	gated channel activity	CACNA1C TMC7 PKD2L1 NMUR2 RYR1 RYR2 RYR3 TPCN1 PKD2	2.13e-03	334	168	9	GO:0022836
GeneOntologyMolecularFunction	alpha-actinin binding	CACNA1C PKD2L1 PKD2	2.21e-03	31	168	3	GO:0051393
GeneOntologyMolecularFunction	transmembrane transporter activity	CACNA1C TPTE ATP6V1B2 ATP13A4 TMEM120B TMC7 PKD2L1 NMUR2 SLC7A6 SLCO1B1 PKDREJ RYR1 RYR2 RYR3 TPCN1 SLC12A3 PKD2L2 ATP11B SLC35B4 PKD2	2.22e-03	1180	168	20	GO:0022857
GeneOntologyMolecularFunction	phospholipase binding	MET TGM2 SNAP91	2.43e-03	32	168	3	GO:0043274
GeneOntologyMolecularFunction	monoatomic cation channel activity	CACNA1C PKD2L1 PKDREJ RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2	2.55e-03	343	168	9	GO:0005261
GeneOntologyBiologicalProcess	phospholipid translocation	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	6.18e-10	55	169	9	GO:0045332
GeneOntologyBiologicalProcess	lipid translocation	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	1.39e-09	60	169	9	GO:0034204
GeneOntologyBiologicalProcess	regulation of membrane lipid distribution	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	2.90e-09	65	169	9	GO:0097035
GeneOntologyBiologicalProcess	aminophospholipid transport	ATP8A2 ATP8B1 ATP11B ATP11C ATP11A	4.27e-09	9	169	5	GO:0015917
GeneOntologyBiologicalProcess	phospholipid transport	ATP8B4 APOA5 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	1.69e-08	106	169	10	GO:0015914
GeneOntologyBiologicalProcess	aminophospholipid translocation	ATP8A2 ATP8B1 ATP11C ATP11A	1.49e-07	7	169	4	GO:0140331
GeneOntologyBiologicalProcess	organophosphate ester transport	ATP8B4 APOA5 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A ATG9A	9.25e-07	162	169	10	GO:0015748
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	CACNA1C RYR1 RYR2 RYR3 CCR5	1.23e-05	37	169	5	GO:0014808
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	CACNA1C TPTE XCR1 ATP6V1B2 ATP13A4 ANK3 TMC7 PKD2L1 ATP8B1 NMUR2 PKDREJ ATP8B2 RYR1 RYR2 RYR3 ALG10B TPCN1 SLC12A3 PKD2L2 ATP11B ALG10 PKD2 ATP11C CCR5	1.40e-05	1115	169	24	GO:0034220
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by endoplasmic reticulum	CACNA1C RYR1 RYR2 RYR3 CCR5	1.60e-05	39	169	5	GO:1903514
GeneOntologyBiologicalProcess	monoatomic ion transport	CACNA1C TPTE XCR1 ATP6V1B2 ATP13A4 ANK3 TMC7 HTR7 PKD2L1 ATP8B1 NMUR2 SLCO1B1 PKDREJ ATP8B2 RYR1 RYR2 RYR3 ALG10B TPCN1 USP2 SLC12A3 PKD2L2 ATP11B ALG10 PKD2 ATP11C CCR5	1.98e-05	1374	169	27	GO:0006811
GeneOntologyBiologicalProcess	sarcoplasmic reticulum calcium ion transport	CACNA1C RYR1 RYR2 RYR3 CCR5	2.92e-05	44	169	5	GO:0070296
GeneOntologyBiologicalProcess	regulation of neuron projection development	KREMEN1 HTR7 ATP8A2 PICALM SLITRK1 PTN MET FBXW8 BRAF SNAP91 FIG4 WASHC5 CCR5 ITM2C TBR1 PREX1	4.54e-05	612	169	16	GO:0010975
GeneOntologyBiologicalProcess	lipid localization	DENND5B ATP8B4 APOA5 ATP8A2 ATP10B ATP8B1 NMUR2 SLCO1B1 ATP8B2 ATP11B ANGPTL3 OSBPL11 ATP11C ATP11A ATG9A	6.67e-05	565	169	15	GO:0010876
GeneOntologyBiologicalProcess	calcium-mediated signaling	CACNA1C XCR1 PDK2 NMUR2 RYR1 RYR2 RYR3 TPCN1 PKD2 CCR5	7.12e-05	266	169	10	GO:0019722
GeneOntologyBiologicalProcess	lipid transport	DENND5B ATP8B4 APOA5 ATP8A2 ATP10B ATP8B1 NMUR2 SLCO1B1 ATP8B2 ATP11B OSBPL11 ATP11C ATP11A ATG9A	7.60e-05	506	169	14	GO:0006869
GeneOntologyBiologicalProcess	cellular response to caffeine	RYR1 RYR2 RYR3	8.50e-05	11	169	3	GO:0071313
GeneOntologyBiologicalProcess	cellular response to calcium ion	GPLD1 INHBB RYR1 RYR3 BRAF PKD2	8.61e-05	88	169	6	GO:0071277
GeneOntologyBiologicalProcess	response to cholesterol	GPLD1 GPR155 INHBB CCR5	8.80e-05	29	169	4	GO:0070723
GeneOntologyBiologicalProcess	calcium ion transmembrane transport	CACNA1C XCR1 ATP13A4 PKD2L1 PKDREJ RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2 CCR5	9.80e-05	392	169	12	GO:0070588
GeneOntologyBiologicalProcess	response to sterol	GPLD1 GPR155 INHBB CCR5	1.66e-04	34	169	4	GO:0036314
GeneOntologyBiologicalProcess	cellular response to purine-containing compound	RYR1 RYR2 RYR3	1.84e-04	14	169	3	GO:0071415
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol	CACNA1C XCR1 RYR1 RYR2 RYR3 PKD2 CCR5	2.04e-04	146	169	7	GO:0051209
GeneOntologyBiologicalProcess	response to mechanical stimulus	HTR7 ATP8A2 PKD2L1 PKDREJ STAT1 RYR2 PTN PKD2L2 PKD2	2.07e-04	247	169	9	GO:0009612
GeneOntologyBiologicalProcess	negative regulation of sequestering of calcium ion	CACNA1C XCR1 RYR1 RYR2 RYR3 PKD2 CCR5	2.13e-04	147	169	7	GO:0051283
GeneOntologyBiologicalProcess	regulation of sequestering of calcium ion	CACNA1C XCR1 RYR1 RYR2 RYR3 PKD2 CCR5	2.32e-04	149	169	7	GO:0051282
GeneOntologyBiologicalProcess	sequestering of calcium ion	CACNA1C XCR1 RYR1 RYR2 RYR3 PKD2 CCR5	2.72e-04	153	169	7	GO:0051208
GeneOntologyBiologicalProcess	calcium ion transport	CACNA1C XCR1 ATP13A4 PKD2L1 PKDREJ RYR1 RYR2 RYR3 TPCN1 USP2 PKD2L2 PKD2 CCR5	3.00e-04	509	169	13	GO:0006816
GeneOntologyBiologicalProcess	cellular response to alkaloid	RYR1 RYR2 RYR3 TGM2	3.16e-04	40	169	4	GO:0071312
GeneOntologyBiologicalProcess	neuron development	NPHP1 KREMEN1 ANK3 HTR7 USP9X ATP8A2 ATP8B1 PICALM SLITRK1 PREX2 ALG10B PTN MET FBXW8 BRAF SNAP91 OR10A4 FIG4 WASHC5 ALG10 KIAA1755 CCR5 ITM2C TBR1 PREX1	3.70e-04	1463	169	25	GO:0048666
GeneOntologyBiologicalProcess	response to calcium ion	GPLD1 INHBB RYR1 RYR2 RYR3 BRAF PKD2	3.71e-04	161	169	7	GO:0051592
GeneOntologyBiologicalProcess	detection of mechanical stimulus	HTR7 PKD2L1 PKDREJ PKD2L2 PKD2	3.78e-04	75	169	5	GO:0050982
GeneOntologyBiologicalProcess	regulation of terminal button organization	PICALM SNAP91	3.96e-04	4	169	2	GO:2000331
GeneOntologyBiologicalProcess	response to purine-containing compound	INHBB STAT1 RYR1 RYR2 RYR3 BRAF PKD2	4.46e-04	166	169	7	GO:0014074
GeneOntologyBiologicalProcess	regulation of mesenchymal cell proliferation	FBXW4 STAT1 PTN FOXF1	4.99e-04	45	169	4	GO:0010464
GeneOntologyBiologicalProcess	detection of external stimulus	HTR7 ATP8A2 PKD2L1 PKDREJ PKD2L2 PKD2 FOXF1	5.71e-04	173	169	7	GO:0009581
GeneOntologyCellularComponent	phospholipid-translocating ATPase complex	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	5.38e-14	14	173	8	GO:1990531
GeneOntologyCellularComponent	transporter complex	CACNA1C ATP6V1B2 ATP8B4 CATSPERE ATP8A2 PKD2L1 ATP10B ATP8B1 ATP8B2 RYR1 RYR2 RYR3 TPCN1 ATP11B PKD2 ATP11C ATP11A	3.41e-06	550	173	17	GO:1990351
GeneOntologyCellularComponent	multivesicular body lumen	PGA4 PGA5 PGA3	1.90e-05	7	173	3	GO:0097486
GeneOntologyCellularComponent	calcium channel complex	CACNA1C CATSPERE PKD2L1 RYR1 RYR2 RYR3	3.17e-05	73	173	6	GO:0034704
GeneOntologyCellularComponent	endosome	PGA4 ATP13A4 WASHC4 APOA5 ATP8A2 UBR4 ATP10B PGA5 PICALM TLR8 TPCN1 ATP11B SNAP91 FIG4 SNX32 WASHC5 SBF2 ANGPTL3 OSBPL11 ATP11C CCR5 ATP11A ATG9A PGA3	3.50e-05	1167	173	24	GO:0005768
GeneOntologyCellularComponent	vacuolar membrane	GPLD1 GPR155 ATP6V1B2 TMEM79 ATP10B TLR8 TPCN1 ATXN3L ATP11B SBF2 ATP11C ATP11A ITM2C ATG9A	8.68e-05	507	173	14	GO:0005774
GeneOntologyCellularComponent	late endosome lumen	PGA4 PGA5 PGA3	8.75e-05	11	173	3	GO:0031906
GeneOntologyCellularComponent	vacuole	GPLD1 GPR155 ATP6V1B2 ANK3 TMEM79 ATP10B TLR8 TPCN1 ATXN3L ATP11B GUSB SBF2 ATP11C ATP11A ITM2C ATG9A PIP4K2C PSAPL1 CTSW	2.09e-04	913	173	19	GO:0005773
GeneOntologyCellularComponent	endoplasmic reticulum membrane	TPTE ATP13A4 TMEM119 ATP10B ATP8B2 TLR8 RYR1 RYR2 RYR3 ALG10B ATXN3L MGST2 OR10A4 SLC35B4 ALG9 RAB3GAP2 ALG10 PKD2 ATP11C ATP11A DNAJC1 ATG9A OTULINL	4.32e-04	1293	173	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	TPTE ATP13A4 TMEM119 ATP10B ATP8B2 TLR8 RYR1 RYR2 RYR3 ALG10B ATXN3L MGST2 OR10A4 SLC35B4 ALG9 RAB3GAP2 ALG10 PKD2 ATP11C ATP11A DNAJC1 ATG9A OTULINL	4.61e-04	1299	173	23	GO:0098827
GeneOntologyCellularComponent	lysosomal membrane	GPLD1 GPR155 ATP6V1B2 TMEM79 ATP10B TLR8 TPCN1 ATXN3L ATP11B ATP11C ATP11A ITM2C	4.84e-04	462	173	12	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	GPLD1 GPR155 ATP6V1B2 TMEM79 ATP10B TLR8 TPCN1 ATXN3L ATP11B ATP11C ATP11A ITM2C	4.84e-04	462	173	12	GO:0098852
GeneOntologyCellularComponent	endosome membrane	ATP13A4 WASHC4 ATP8A2 ATP10B TLR8 TPCN1 ATP11B SNAP91 FIG4 WASHC5 SBF2 OSBPL11 ATP11C ATG9A	5.02e-04	602	173	14	GO:0010008
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	TPTE ATP13A4 TMEM119 ATP10B ATP8B2 TLR8 RYR1 RYR2 RYR3 ALG10B ATXN3L MGST2 OR10A4 SLC35B4 ALG9 RAB3GAP2 ALG10 PKD2 ATP11C ATP11A DNAJC1 ATG9A OTULINL	6.19e-04	1327	173	23	GO:0042175
GeneOntologyCellularComponent	motile cilium	NPHP1 PRAMEF7 CATSPERE PRAMEF8 MET MROH2B PKD2 DAAM1 DNAH8 DNAH11	7.75e-04	355	173	10	GO:0031514
GeneOntologyCellularComponent	sarcolemma	CACNA1C ANK3 OBSCN CHRM4 RYR1 RYR2 RYR3	1.05e-03	190	173	7	GO:0042383
GeneOntologyCellularComponent	lysosome	GPLD1 GPR155 ATP6V1B2 ANK3 TMEM79 ATP10B TLR8 TPCN1 ATXN3L ATP11B GUSB ATP11C ATP11A ITM2C PSAPL1 CTSW	1.18e-03	811	173	16	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	GPLD1 GPR155 ATP6V1B2 ANK3 TMEM79 ATP10B TLR8 TPCN1 ATXN3L ATP11B GUSB ATP11C ATP11A ITM2C PSAPL1 CTSW	1.18e-03	811	173	16	GO:0000323
GeneOntologyCellularComponent	extrinsic component of presynaptic endocytic zone membrane	PICALM SNAP91	1.39e-03	7	173	2	GO:0098894
GeneOntologyCellularComponent	Z disc	CACNA1C ANK3 OBSCN RYR1 RYR2 RYR3	1.63e-03	151	173	6	GO:0030018
GeneOntologyCellularComponent	early endosome membrane	ATP13A4 WASHC4 TPCN1 ATP11B FIG4 WASHC5 ATP11C	1.97e-03	212	173	7	GO:0031901
GeneOntologyCellularComponent	early endosome	ATP13A4 WASHC4 APOA5 PICALM TPCN1 ATP11B FIG4 WASHC5 ANGPTL3 ATP11C ATP11A	2.28e-03	481	173	11	GO:0005769
GeneOntologyCellularComponent	junctional membrane complex	RYR1 RYR3	2.36e-03	9	173	2	GO:0030314
GeneOntologyCellularComponent	recycling endosome membrane	ATP13A4 TPCN1 ATP11B ATP11C ATG9A	2.41e-03	112	173	5	GO:0055038
GeneOntologyCellularComponent	late endosome	PGA4 ATP13A4 APOA5 ATP10B PGA5 FIG4 OSBPL11 ATG9A PGA3	2.52e-03	348	173	9	GO:0005770
GeneOntologyCellularComponent	recycling endosome	ATP13A4 TPCN1 ATP11B FIG4 ATP11C ATP11A ATG9A	2.55e-03	222	173	7	GO:0055037
GeneOntologyCellularComponent	I band	CACNA1C ANK3 OBSCN RYR1 RYR2 RYR3	2.63e-03	166	173	6	GO:0031674
GeneOntologyCellularComponent	junctional sarcoplasmic reticulum membrane	RYR1 RYR2	2.93e-03	10	173	2	GO:0014701
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	ALG10B ALG9 PKD2	3.00e-03	35	173	3	GO:0098553
GeneOntologyCellularComponent	cation channel complex	CACNA1C CATSPERE PKD2L1 RYR1 RYR2 RYR3 PKD2	3.49e-03	235	173	7	GO:0034703
Domain	P_typ_ATPase_c	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	9.90e-14	14	167	8	IPR032630
Domain	P-type_ATPase_N	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	9.90e-14	14	167	8	IPR032631
Domain	P-type_ATPase_IV	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	9.90e-14	14	167	8	IPR006539
Domain	PhoLip_ATPase_C	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	9.90e-14	14	167	8	PF16212
Domain	PhoLip_ATPase_N	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	9.90e-14	14	167	8	PF16209
Domain	-	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	6.92e-12	32	167	9	3.40.1110.10
Domain	-	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	6.92e-12	32	167	9	2.70.150.10
Domain	ATPase_P-typ_cyto_domN	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	1.70e-11	35	167	9	IPR023299
Domain	ATPase_P-typ_P_site	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.25e-11	36	167	9	IPR018303
Domain	P_typ_ATPase	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.25e-11	36	167	9	IPR001757
Domain	ATPASE_E1_E2	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.25e-11	36	167	9	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.95e-11	37	167	9	IPR008250
Domain	E1-E2_ATPase	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.95e-11	37	167	9	PF00122
Domain	-	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	5.32e-09	64	167	9	3.40.50.1000
Domain	PKD_2	PKD2L1 PKDREJ PKD2L2 PKD2	3.06e-08	5	167	4	IPR003915
Domain	HAD-like_dom	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	3.54e-08	79	167	9	IPR023214
Domain	Ryanodine_rcpt	RYR1 RYR2 RYR3	7.02e-07	3	167	3	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2 RYR3	7.02e-07	3	167	3	IPR009460
Domain	RyR	RYR1 RYR2 RYR3	7.02e-07	3	167	3	PF02026
Domain	RR_TM4-6	RYR1 RYR2 RYR3	7.02e-07	3	167	3	PF06459
Domain	Ryan_recept	RYR1 RYR2 RYR3	7.02e-07	3	167	3	IPR013333
Domain	PKD_channel	PKD2L1 PKDREJ PKD2L2 PKD2	1.94e-06	11	167	4	PF08016
Domain	PKD1_2_channel	PKD2L1 PKDREJ PKD2L2 PKD2	1.94e-06	11	167	4	IPR013122
Domain	RIH_assoc-dom	RYR1 RYR2 RYR3	1.38e-05	6	167	3	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR2 RYR3	1.38e-05	6	167	3	PF08709
Domain	RIH_assoc	RYR1 RYR2 RYR3	1.38e-05	6	167	3	PF08454
Domain	RIH_dom	RYR1 RYR2 RYR3	1.38e-05	6	167	3	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2 RYR3	1.38e-05	6	167	3	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2 RYR3	1.38e-05	6	167	3	IPR015925
Domain	-	RYR1 RYR2 RYR3	1.38e-05	6	167	3	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR2 RYR3	1.38e-05	6	167	3	PF01365
Domain	Aspartic_peptidase_N	PGA4 PGA5 PGA3	2.39e-05	7	167	3	IPR012848
Domain	A1_Propeptide	PGA4 PGA5 PGA3	2.39e-05	7	167	3	PF07966
Domain	EF-hand-dom_pair	CACNA1C PKD2L1 STAT1 RYR1 RYR2 STAT4 RYR3 TPCN1 NECAB1 PKD2 PPP2R3C	5.64e-05	287	167	11	IPR011992
Domain	Alg10	ALG10B ALG10	7.95e-05	2	167	2	IPR016900
Domain	Clathrin_AP_2	PICALM SNAP91	7.95e-05	2	167	2	IPR014712
Domain	DIE2_ALG10	ALG10B ALG10	7.95e-05	2	167	2	PF04922
Domain	-	PICALM SNAP91	7.95e-05	2	167	2	1.20.58.150
Domain	MIR	RYR1 RYR2 RYR3	8.05e-05	10	167	3	PF02815
Domain	Aspartic_peptidase_A1	PGA4 PGA5 PGA3	8.05e-05	10	167	3	IPR001461
Domain	MIR_motif	RYR1 RYR2 RYR3	8.05e-05	10	167	3	IPR016093
Domain	MIR	RYR1 RYR2 RYR3	8.05e-05	10	167	3	PS50919
Domain	MIR	RYR1 RYR2 RYR3	8.05e-05	10	167	3	SM00472
Domain	PEPTIDASE_A1	PGA4 PGA5 PGA3	8.05e-05	10	167	3	IPR033121
Domain	Asp	PGA4 PGA5 PGA3	8.05e-05	10	167	3	PF00026
Domain	PEPTIDASE_A1	PGA4 PGA5 PGA3	8.05e-05	10	167	3	PS51767
Domain	-	PGA4 PGA5 PGA3	1.46e-04	12	167	3	2.40.70.10
Domain	ASP_PROTEASE	PGA4 PGA5 PGA3	1.46e-04	12	167	3	PS00141
Domain	Aspartic_peptidase_AS	PGA4 PGA5 PGA3	1.88e-04	13	167	3	IPR001969
Domain	Peptidase_aspartic_dom	PGA4 PGA5 PGA3	4.35e-04	17	167	3	IPR021109
Domain	ANTH_dom	PICALM SNAP91	4.71e-04	4	167	2	IPR011417
Domain	COE	EBF3 EBF1	4.71e-04	4	167	2	PS01345
Domain	ANTH	PICALM SNAP91	4.71e-04	4	167	2	PF07651
Domain	Transcription_factor_COE	EBF3 EBF1	4.71e-04	4	167	2	IPR003523
Domain	PC1	PKD2L1 PKD2L2	4.71e-04	4	167	2	IPR000434
Domain	COE_HLH	EBF3 EBF1	4.71e-04	4	167	2	IPR032201
Domain	COE_DBD	EBF3 EBF1	4.71e-04	4	167	2	IPR032200
Domain	Transcription_factor_COE_CS	EBF3 EBF1	4.71e-04	4	167	2	IPR018350
Domain	COE1_HLH	EBF3 EBF1	4.71e-04	4	167	2	PF16423
Domain	COE1_DBD	EBF3 EBF1	4.71e-04	4	167	2	PF16422
Domain	Ion_trans_dom	CACNA1C TPTE RYR1 RYR2 RYR3 TPCN1	5.62e-04	114	167	6	IPR005821
Domain	Ion_trans	CACNA1C TPTE RYR1 RYR2 RYR3 TPCN1	5.62e-04	114	167	6	PF00520
Domain	-	PKD2L1 STAT1 RYR1 RYR2 STAT4 RYR3 NECAB1 PKD2 PPP2R3C	5.82e-04	261	167	9	1.10.238.10
Domain	DEP	GPR155 PREX2 PREX1	9.54e-04	22	167	3	PF00610
Domain	DEP	GPR155 PREX2 PREX1	9.54e-04	22	167	3	PS50186
Domain	DEP	GPR155 PREX2 PREX1	9.54e-04	22	167	3	SM00049
Domain	ARM-type_fold	USP9X UBR4 BTAF1 RALGAPA2 RYR3 PPP2R5E PI4KA MROH2B ANKAR DAAM1	9.72e-04	339	167	10	IPR016024
Domain	DEP_dom	GPR155 PREX2 PREX1	1.09e-03	23	167	3	IPR000591
Domain	STAT_TF_DNA-bd_sub	STAT1 STAT4	1.62e-03	7	167	2	IPR012345
Domain	STAT	STAT1 STAT4	1.62e-03	7	167	2	IPR001217
Domain	STAT_int	STAT1 STAT4	1.62e-03	7	167	2	SM00964
Domain	STAT_TF_DNA-bd	STAT1 STAT4	1.62e-03	7	167	2	IPR013801
Domain	STAT_bind	STAT1 STAT4	1.62e-03	7	167	2	PF02864
Domain	STAT_int	STAT1 STAT4	1.62e-03	7	167	2	PF02865
Domain	-	STAT1 STAT4	1.62e-03	7	167	2	1.10.532.10
Domain	STAT_alpha	STAT1 STAT4	1.62e-03	7	167	2	PF01017
Domain	-	STAT1 STAT4	1.62e-03	7	167	2	1.20.1050.20
Domain	STAT_TF_prot_interaction	STAT1 STAT4	1.62e-03	7	167	2	IPR013799
Domain	MAPEG-like_dom	TMEM79 MGST2	1.62e-03	7	167	2	IPR023352
Domain	STAT_TF_coiled-coil	STAT1 STAT4	1.62e-03	7	167	2	IPR015988
Domain	-	STAT1 STAT4	1.62e-03	7	167	2	2.60.40.630
Domain	-	TMEM79 MGST2	1.62e-03	7	167	2	1.20.120.550
Domain	IPT	EBF3 EBF1 MET	1.75e-03	27	167	3	SM00429
Domain	STAT_TF_alpha	STAT1 STAT4	2.15e-03	8	167	2	IPR013800
Domain	DHC_N1	DNAH8 DNAH11	2.15e-03	8	167	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH8 DNAH11	2.15e-03	8	167	2	IPR013594
Domain	TIG	EBF3 EBF1 MET	2.63e-03	31	167	3	PF01833
Domain	ENTH	PICALM SNAP91	2.75e-03	9	167	2	PS50942
Domain	ENTH	PICALM SNAP91	2.75e-03	9	167	2	SM00273
Domain	IPT	EBF3 EBF1 MET	2.88e-03	32	167	3	IPR002909
Domain	ENTH	PICALM SNAP91	3.41e-03	10	167	2	IPR013809
Domain	Hydrolase_3	ATP8B4 ATP10B	3.41e-03	10	167	2	PF08282
Domain	Serpin_dom	HMSD SERPINI2 SERPINA7	4.04e-03	36	167	3	IPR023796
Domain	SERPIN	HMSD SERPINI2 SERPINA7	4.36e-03	37	167	3	PS00284
Domain	PH	SH2B3 OBSCN PREX2 SBF2 OSBPL11 PLEKHA2 PREX1	4.60e-03	229	167	7	PF00169
Domain	Serpin	HMSD SERPINI2 SERPINA7	4.71e-03	38	167	3	PF00079
Domain	EF_hand_dom	PKD2L1 RYR1 RYR2 RYR3 NECAB1 PKD2 PPP2R3C	4.93e-03	232	167	7	IPR002048
Domain	GDS_CDC24_CS	OBSCN PREX2 PREX1	5.07e-03	39	167	3	IPR001331
Domain	Serpin_fam	HMSD SERPINI2 SERPINA7	5.07e-03	39	167	3	IPR000215
Domain	Inhibin_asu	INHBB GDF3	5.81e-03	13	167	2	IPR002405
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	ATP6V1B2 ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 RYR1 RYR2 RYR3 TPCN1 ATP11B ATP11C ATP11A	1.24e-09	176	134	14	MM15718
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	ATP6V1B2 ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 RYR1 RYR2 RYR3 TPCN1 ATP11B ATP11C ATP11A	2.06e-09	183	134	14	M997
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.12e-09	55	134	9	M971
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP13A4 ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.96e-09	57	134	9	MM15643
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	CACNA1C RYR1 RYR2 RYR3	2.45e-06	11	134	4	M47958
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	ATP6V1B2 ATP13A4 ATP8B4 APOA5 ATP8A2 ATP10B ATP8B1 SLC7A6 SLCO1B1 ATP8B2 RYR1 RYR2 RYR3 TPCN1 SLC12A3 ATP11B SLC35B4 ANGPTL3 ATP11C ATP11A	6.52e-06	681	134	20	MM14985
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	ATP6V1B2 ATP13A4 ATP8B4 APOA5 ATP8A2 ATP10B ATP8B1 SLC7A6 SLCO1B1 ATP8B2 RYR1 RYR2 RYR3 TPCN1 SLC12A3 ATP11B SLC35B4 ANGPTL3 ATP11C ATP11A	2.03e-05	736	134	20	M27287
Pathway	WP_GASTRIC_ACID_PRODUCTION	PGA4 PGA5 PGA3	1.31e-04	11	134	3	M39726
Pathway	REACTOME_PI_METABOLISM	TPTE FIG4 PI4KA SBF2 PLEKHA2 PIP4K2C	1.46e-04	84	134	6	M676
Pathway	WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING	RYR1 RYR2 RYR3	2.24e-04	13	134	3	M39589
Pubmed	Differential expression of putative transbilayer amphipath transporters.	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	4.01e-16	13	173	8	11015572
Pubmed	Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.	ATP8B1 ATP8B2 ATP11C ATP11A	5.91e-10	4	173	4	25315773
Pubmed	The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease.	ATP8A2 ATP8B1 ATP8B2 ATP11B ATP11C	7.10e-10	10	173	5	15919184
Pubmed	ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the trans-Golgi network in a CDC50 protein-independent manner.	ATP10B ATP8B1 ATP11B ATP11C ATP11A	2.21e-09	12	173	5	21914794
Pubmed	Human Type IV P-type ATPases That Work as Plasma Membrane Phospholipid Flippases and Their Regulation by Caspase and Calcium.	ATP8A2 ATP10B ATP11C ATP11A	2.95e-09	5	173	4	26567335
Pubmed	Polycystin channels and kidney disease.	PKD2L1 PKDREJ PKD2L2 PKD2	2.95e-09	5	173	4	11698076
Pubmed	Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases.	ATP8B4 ATP8A2 ATP8B1 ATP8B2	2.05e-08	7	173	4	20947505
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	CACNA1C RYR1 RYR2 RYR3	4.08e-08	8	173	4	11784029
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	18403125
Pubmed	The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	7926498
Pubmed	Crystal structure of human pepsinogen A.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	9561228
Pubmed	The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	21455714
Pubmed	Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	19800305
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	7876312
Pubmed	Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	24170207
Pubmed	Relationships between the human pepsinogen DNA and protein polymorphisms.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	3014868
Pubmed	The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2799289
Pubmed	CRYSTALLINE PEPSIN : I. ISOLATION AND TESTS OF PURITY.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	19872561
Pubmed	Human pepsinogen A (PGA): an informative gene complex located at 11q13.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	1968039
Pubmed	Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	8053437
Pubmed	Family and population studies on the human pepsinogen A multigene family.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2566575
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	22948152
Pubmed	Immunoblot technique to visualise serum pepsinogen A isozymogen patterns.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2229438
Pubmed	Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	25314140
Pubmed	Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	19890696
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	10788707
Pubmed	Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	8244094
Pubmed	Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	21407214
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	7621815
Pubmed	Isolation of an activation intermediate and determination of the amino acid sequence of the activation segment of human pepsinogen A.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	6774973
Pubmed	Primary structure of human pepsinogen gene.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	6300126
Pubmed	Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	22304859
Pubmed	Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	24004680
Pubmed	Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	8038355
Pubmed	Human pepsinogen A isozymogen patterns in serum and gastric mucosa.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2227273
Pubmed	Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	23034090
Pubmed	A possible association of low pepsinogen I and pepsinogen I/II with low and high body weight in Japanese men.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	24125879
Pubmed	Effects of omeprazole and lansoprazole on fasting and postprandial serum gastrin and serum pepsinogen A and C.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	8751234
Pubmed	Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	3554488
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	10473538
Pubmed	Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	23521833
Pubmed	Close linkage of human chromosomal pepsinogen A genes.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	3017318
Pubmed	Serum pepsinogen test for early detection of gastric cancer in a European country.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	21989121
Pubmed	Serum antibodies to H+,K+-ATPase, serum pepsinogen A and Helicobacter pylori in relation to gastric mucosa morphology in patients with low or low-normal concentrations of serum cobalamins.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	9855083
Pubmed	Advantages of serum pepsinogen A combined with gastrin or pepsinogen C as first-line analytes in the evaluation of suspected cobalamin deficiency: a study in patients previously not subjected to gastrointestinal surgery.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	9797498
Pubmed	The glomerular sieving of pepsinogen A and C in man.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2478370
Pubmed	Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	3815274
Pubmed	Pepsinogens: physiology, pharmacology pathophysiology and exercise.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	10675278
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	18434746
Pubmed	Pepsinogen A polymorphism in gastric mucosa and urine, with special reference to patients with gastric cancer.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	3780036
Pubmed	Identification of a Glu greater than Lys substitution in the activation segment of human pepsinogen A-3 and -5 isozymogens by peptide mapping using endoproteinase Lys-C.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2901984
Pubmed	Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).	PKD2L1 PKDREJ PKD2L2	1.21e-07	3	173	3	10602361
Pubmed	Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	3839486
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR2 RYR3	1.21e-07	3	173	3	9204703
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	21881589
Pubmed	Assignment of the pepsinogen gene complex (PGA) to human chromosome region 11q13 by in situ hybridization.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	3467902
Pubmed	The pepsinogens of human gastric mucosa.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	4586732
Pubmed	Genomic structure and evolution of the human pepsinogen A multigene family.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2892778
Pubmed	The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	24383519
Pubmed	Gene structures of pepsinogens A and C.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	1455184
Pubmed	Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2831884
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR2 RYR3	1.21e-07	3	173	3	12213830
Pubmed	Localization of pepsinogen (A and C) and cellular differentiation of pepsinogen-synthesizing cells in the human gastric mucosa.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	2032552
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	9242641
Pubmed	Analysis of the promoter of a human pepsinogen A gene.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	1812762
Pubmed	O6-methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. The EUROGAST Study Group.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	7923573
Pubmed	Fast detection of phosphorylation of human pepsinogen A, human pepsinogen C and swine pepsinogen using a combination of reversed-phase high-performance liquid chromatography and capillary zone electrophoresis for peptide mapping.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	9061458
Pubmed	Polycystin-2 expression and function in adult mouse lacrimal acinar cells.	PKD2L1 PKD2L2 PKD2	1.21e-07	3	173	3	21508103
Pubmed	Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	12588289
Pubmed	Asymmetric distribution of dynamic calcium signals in the node of mouse embryo during left-right axis formation.	PDK2 PKD2 DNAH11	1.21e-07	3	173	3	23357539
Pubmed	Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	23897256
Pubmed	An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	11566730
Pubmed	The effect of acute and chronic protein loading on urinary pepsinogen A excretion.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	1956484
Pubmed	Transcription regulation of human and porcine pepsinogen A.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	8540382
Pubmed	Exploratory findings of audiometry in adult patients with otitis media with high pepsinogen concentrations: a preliminary study.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	22992016
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	25239916
Pubmed	The role of serum pepsinogen in the detection of gastric cancer.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	20981206
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR2 RYR3	1.21e-07	3	173	3	11159936
Pubmed	Gastric chief cell-specific transcription of the pepsinogen A gene.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	8504820
Pubmed	Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	21970995
Pubmed	Serum pepsinogens in gastric cancer screening.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	20428942
Pubmed	The relationship of Helicobacter pylori colonization, the serum pepsinogen A level, and gastric resection.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	9525001
Pubmed	Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	7886402
Pubmed	Serum pepsinogen and gastric cancer screening.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	17379991
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	4600883
Pubmed	Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.	PGA4 PGA5 PGA3	1.21e-07	3	173	3	21547904
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR2 RYR3	1.21e-07	3	173	3	7635066
Pubmed	Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells.	PKD2L1 PKDREJ PKD2L2 PKD2	1.21e-07	10	173	4	16805797
Pubmed	New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.	CACNA1C RYR1 RYR2 RYR3	2.84e-07	12	173	4	19095005
Pubmed	Characterization of P4 ATPase Phospholipid Translocases (Flippases) in Human and Rat Pancreatic Beta Cells: THEIR GENE SILENCING INHIBITS INSULIN SECRETION.	ATP8A2 ATP8B1 ATP8B2	4.82e-07	4	173	3	26240149
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR1 RYR2 RYR3	4.82e-07	4	173	3	23413940
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR1 RYR2 RYR3	4.82e-07	4	173	3	9607712
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR1 RYR2 RYR3	4.82e-07	4	173	3	23482488
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR1 RYR2 RYR3	4.82e-07	4	173	3	18206662
Pubmed	Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes.	PGA4 PGA5 PGA3	4.82e-07	4	173	3	23047493
Pubmed	Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development.	PGA4 PGA5 PGA3	4.82e-07	4	173	3	11915945
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR2 RYR3	4.82e-07	4	173	3	9384575
Pubmed	Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers.	PGA4 PGA5 PGA3	4.82e-07	4	173	3	8322031
Cytoband	16q13	SLC12A3 NLRC5 NUP93	3.43e-04	36	173	3	16q13
Cytoband	20p11.22	RALGAPA2 RIN2	3.89e-04	8	173	2	20p11.22
Cytoband	Ensembl 112 genes in cytogenetic band chr16q13	SLC12A3 NLRC5 NUP93	4.69e-04	40	173	3	chr16q13
GeneFamily	ATPase phospholipid transporting	ATP8B4 ATP8A2 ATP10B ATP8B1 ATP8B2 ATP11B ATP11C ATP11A	2.74e-14	15	126	8	1210
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2 RYR3	3.31e-07	3	126	3	287
GeneFamily	Alpha-1,2-glucosyltransferases	ALG10B ALG10	4.82e-05	2	126	2	448
GeneFamily	WASH complex	WASHC4 WASHC5	7.10e-04	6	126	2	1331
GeneFamily	Transient receptor potential cation channels	PKD2L1 PKD2L2 PKD2	9.53e-04	28	126	3	249
GeneFamily	CD molecules\|Toll like receptors	TLR8 TLR10	2.09e-03	10	126	2	948
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW4 FBXW8	2.54e-03	11	126	2	559
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	GPR155 HTR7 SH2B3 USP9X SH3BGRL UBR4 BTAF1 SLC7A6 PICALM ATP8B2 STAT1 STAT4 PPP2R5E PELO STYX ATP11B RAB3GAP2 YPEL5 CLEC2D NLRC5 PLEKHA2 CCR5 BIN2 ITM2C PREX1 CTSW	5.62e-06	1492	173	26	M40023
Coexpression	ZHONG_PFC_MAJOR_TYPES_MICROGLIA	NPL ATP8B4 SH2B3 IRF8 TMEM119 RYR1 TLR10 MGST2 RIN2 BIN2 ITM2C OTULINL CPVL	7.44e-06	438	173	13	M39077
Coexpression	HU_FETAL_RETINA_MICROGLIA	NPL ATP8B4 SH2B3 SH3BGRL IRF8 TLR10 MGST2 BIN2 OTULINL CPVL PREX1	5.00e-05	382	173	11	M39266
Coexpression	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN	NPL SH2B3 CYP27A1 SMC4 PICALM MAP3K4 OSBPL11 OTULINL	5.56e-05	199	173	8	M9532
Coexpression	GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN	NPL CYP27A1 FBXW4 TLR8 FIG4 RIN2 CCR5 CPVL	5.76e-05	200	173	8	M4616
Coexpression	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	FBXW4 ATP8B2 USP2 VWA3B DNAJC1 CPVL DNAH8 PREX1	5.76e-05	200	173	8	M9363
Coexpression	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN	ATP8B4 TMEM120B SMC4 ATP8B2 STAT4 TTLL12 DNAJC1 PREX1	5.76e-05	200	173	8	M7157
Coexpression	GSE30083_SP3_VS_SP4_THYMOCYTE_DN	ATP8B4 ATP8A2 IRF8 STAT4 RIN2 DAAM1 DNAH8 CTSW	5.76e-05	200	173	8	M5037
Coexpression	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP	ATP8B4 SMC4 ATP8B1 MAP3K4 ATP11A DAAM1 TMEM181 CTSW	5.76e-05	200	173	8	M5074
Coexpression	GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN	NPL ATP6V1B2 WASHC4 SH2B3 PICALM RIN2 TNFAIP2 CPVL	5.76e-05	200	173	8	M4480
ToppCell	facs-Marrow-KLS-18m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XCR1 ATP8B4 HTR7 TMEM119 MET GUSB ITM2C NUP93 OTULINL	6.03e-08	190	173	9	c03c735a0ed850bf460a1847f5e2dd61753e577d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH11 OBSCN EBF1 PREX2 RYR2 PTN ITM2C OTULINL FOXF1	6.31e-08	191	173	9	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH11 OBSCN EBF1 PREX2 RYR2 PTN ITM2C OTULINL FOXF1	6.31e-08	191	173	9	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid-Microglia\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	NPL ATP8B4 IRF8 TMEM119 TLR10 MGST2 BIN2 OTULINL CPVL	8.58e-08	198	173	9	c0d33629438504a1545e07f0e5af2e76f50fd55b
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	NPL ATP8B4 IRF8 TMEM119 TLR10 MGST2 BIN2 OTULINL CPVL	8.58e-08	198	173	9	2b93995f66c7352acc25d6c71d025b847881dacd
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	NPL ATP8B4 IRF8 TMEM119 RYR1 MGST2 RIN2 OTULINL CPVL	9.35e-08	200	173	9	01d707c4f8ee0daac635b7260937b1baebc6fc23
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPL ATP8B4 HTR7 SH2B3 IRF8 RYR1 TNFAIP2 CPVL PREX1	9.35e-08	200	173	9	f3dc07a7cc8cf041da8fe610d21af595818cf2d8
ToppCell	droplet-Marrow-BM-30m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM120B INHBB CHST1 HID1 PICALM CLEC2D NLRC5 CTSW	3.35e-07	169	173	8	8e7a30eb546fc6fa184ebb76f54b74b278005a84
ToppCell	10x3'2.3-week_14-16-Myeloid_DC-DC-DC_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IRF8 ATP10B B3GNT7 HHLA2 SLC12A3 MGST2 CCR5 ITM2C	4.00e-07	173	173	8	a361474ad6f058bb3d3f9671bae697205535090b
ToppCell	droplet-Heart-HEART-1m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPLD1 ANK3 ATP8A2 B3GNT7 CHST1 HID1 RYR3 MET	4.00e-07	173	173	8	9dc7746a84f0e268a7c061e1bbcd5e31903034dc
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B B3GNT7 PREX2 PTN ZFHX4 RIN2 DNAH11	5.88e-07	182	173	8	8a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B B3GNT7 PREX2 PTN ZFHX4 RIN2 DNAH11	5.88e-07	182	173	8	e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCell	Control-APC-like-Dendritic_cells\|Control / group, cell type (main and fine annotations)	XCR1 ATP8B4 SH2B3 IRF8 PICALM SLC12A3 CPVL PREX1	6.13e-07	183	173	8	8f9c8e2436f18ea7c265b08e4e149e19cb513a16
ToppCell	COVID-19-APC-like\|COVID-19 / group, cell type (main and fine annotations)	XCR1 ATP8B4 HTR7 IRF8 TLR10 SLC12A3 CPVL PREX1	6.13e-07	183	173	8	b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9
ToppCell	HSPCs-Mono_prog.\|World / Lineage and Cell class	ATP6V1B2 ATP8B4 IRF8 MET MGST2 GUSB BIN2 OTULINL	6.13e-07	183	173	8	1b73070baa9e5d5ada4ce25a77741630af9c1a3a
ToppCell	COVID-19-APC-like-Dendritic_cells\|COVID-19 / group, cell type (main and fine annotations)	XCR1 ATP8B4 HTR7 IRF8 TLR10 SLC12A3 CPVL PREX1	6.13e-07	183	173	8	703364836b42aa6ac6c68b42b700ac23c4a1afc7
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B B3GNT7 PREX2 PTN ZFHX4 RIN2 DNAH11	6.65e-07	185	173	8	2e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B B3GNT7 PREX2 PTN ZFHX4 RIN2 DNAH11	6.65e-07	185	173	8	7aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B B3GNT7 PREX2 PTN ZFHX4 RIN2 DNAH11	6.65e-07	185	173	8	fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B B3GNT7 PREX2 PTN ZFHX4 RIN2 DNAH11	6.65e-07	185	173	8	efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	ATP8B4 NLRP7 STAT4 CLEC2D NLRC5 BIN2 PREX1 CTSW	6.65e-07	185	173	8	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CYP27A1 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	7.21e-07	187	173	8	97e520705491c8f52a32025311a9fa7b9176979a
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN PLEKHA2	7.21e-07	187	173	8	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	7.51e-07	188	173	8	505b6b4277d7dea87aee27191d0acca67928b8e6
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN FOXF1	7.51e-07	188	173	8	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	facs-Marrow-KLS-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XCR1 ATP8B4 HTR7 IRF8 MET GUSB ITM2C OTULINL	7.82e-07	189	173	8	b28a0e2d5a5f512f9b137b162b195bdc3d5ee9ba
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	7.82e-07	189	173	8	784ace2be87f2ecb19490f4974f63a559516e0eb
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CYP27A1 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	7.82e-07	189	173	8	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	7.82e-07	189	173	8	37ecbd73408d462b47d7e5611f203143e08a2689
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 CYP27A1 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755	8.13e-07	190	173	8	07f21386ea6eb23416a537d2250e3042efe93fb0
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CYP27A1 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	8.13e-07	190	173	8	ae97df1b06bcd46c05759b53c35dc8fea97f4ac1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	8.13e-07	190	173	8	2de8e4cfeee350a9a76af749d6ce58d948c129b8
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CYP27A1 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	8.46e-07	191	173	8	2b056cbe2e82e056e1f798974999378460eb1d16
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ATP10B PREX2 PTN ZFHX4 RIN2 KIAA1755 PREX1	8.46e-07	191	173	8	a90c8ab2077e52bbc998457c85a1b9867f9c8c93
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMC7 ATP8B1 EBF1 PREX2 RYR3 CC2D2B TGM2 PREX1	9.15e-07	193	173	8	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)\|Adult / Lineage, Cell type, age group and donor	NPL ATP8B4 SH2B3 RYR1 TPCN1 TNFAIP2 CPVL PREX1	9.15e-07	193	173	8	31c0978ba78c9516d498aec0798902e57555e557
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	NPL ATP8B4 SH2B3 RYR1 TPCN1 TNFAIP2 CPVL PREX1	9.52e-07	194	173	8	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	XCR1 HTR7 SH2B3 IRF8 TLR10 SLC12A3 OTULINL CPVL	9.52e-07	194	173	8	59180fe75be386530f1be668a37e4ada2eb19ddc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPL XCR1 ATP8B4 SH2B3 IRF8 RYR1 CPVL PREX1	9.89e-07	195	173	8	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NPL ATP8B4 HTR7 SH2B3 RYR1 BIN2 OTULINL CPVL	1.03e-06	196	173	8	ce3709adbde7559b40c964888935914f66003247
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPR155 ATP8B4 STAT4 CLEC2D NLRC5 BIN2 PREX1 CTSW	1.07e-06	197	173	8	b803c07072a7860497d07a3be358a28a24359cbf
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	XCR1 ATP8B4 SH2B3 IRF8 TLR10 OR10A4 CPVL PREX1	1.07e-06	197	173	8	e0fc098bfb5a8b7824ae339f3adda30f78360d0b
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN PLEKHA2	1.07e-06	197	173	8	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN PLEKHA2	1.07e-06	197	173	8	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KREMEN1 INHBB PKD2L1 TMEM119 RYR3 PTN SERPINI2 FOXF1	1.07e-06	197	173	8	467e7cbf511d3bcc701923603032aaf0bba2736d
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	SH2B3 CYP27A1 SBF2 PLEKHA2 BIN2 TNFAIP2 CPVL PREX1	1.11e-06	198	173	8	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPL ATP8B4 HTR7 SH2B3 CYP27A1 IRF8 TNFAIP2 CPVL	1.11e-06	198	173	8	6a4161680b46b2c12353a693c403b5a4bb3da03f
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP6V1B2 ATP8B4 HTR7 SH2B3 IRF8 RYR1 TLR10 PREX1	1.15e-06	199	173	8	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	NPL ATP8B4 IRF8 TMEM119 RYR1 RIN2 BIN2 CPVL	1.15e-06	199	173	8	4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPL ATP8B4 HTR7 SH2B3 IRF8 TNFAIP2 CPVL PREX1	1.15e-06	199	173	8	6ce7612ee2ae211eb0f73391e96089ad5431c537
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	NPL ATP8B4 IRF8 TMEM119 RYR1 RIN2 BIN2 CPVL	1.15e-06	199	173	8	3ba48a4715d5e9387650aa97e0c5d7f7897bf380
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	NPL ATP8B4 IRF8 TMEM119 RYR1 MGST2 RIN2 CPVL	1.20e-06	200	173	8	0eccf41edefc3b8b5d0316f57d5ba572949aec2b
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN ITM2C	1.20e-06	200	173	8	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ATP8B4 HIPK4 SH2B3 LGALS12 USP2 FIG4 ITM2C OTULINL	1.20e-06	200	173	8	0b02f3ca3d8612ed7af46381195b0ed5591313cf
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYH11 OBSCN EBF1 PREX2 RYR2 PTN ITM2C FOXF1	1.20e-06	200	173	8	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPL ATP8B4 SH2B3 IRF8 RYR1 TNFAIP2 CPVL PREX1	1.20e-06	200	173	8	ad52b38df5c71f28829b04cd0e6b97f0f9f7610a
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYH11 OBSCN EBF1 PREX2 RYR2 PTN ITM2C FOXF1	1.20e-06	200	173	8	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Bronchial-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN ITM2C	1.20e-06	200	173	8	362706445edb33b313684efe50b1f44f5f816e67
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYH11 OBSCN EBF1 PREX2 RYR2 PTN ITM2C FOXF1	1.20e-06	200	173	8	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	XCR1 ATP8B4 HTR7 SH2B3 IRF8 TLR10 CPVL PREX1	1.20e-06	200	173	8	41a206350eff2a196ccc1a36a9636a87c74f6962
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	NPL ATP8B4 SH2B3 IRF8 TMEM119 RYR1 MGST2 RIN2	1.20e-06	200	173	8	26251ed8c7fa7e87973d6f59bd398c88ad025395
ToppCell	343B-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	XCR1 TMEM120B WASF3 NLRC5 PLEKHA2 CPVL RAPGEFL1	2.43e-06	154	173	7	71d33b5dbfab5820e3daddb01806a69116ba8008
ToppCell	Leuk-UTI-Myeloid-tDC\|Leuk-UTI / Disease, Lineage and Cell Type	IRF8 B3GNT7 HMSD SERPINI2 SLC12A3 ITM2C OTULINL	3.26e-06	161	173	7	51b9f60986ed2e8e2297d31c80462c3ab65a2e5e
ToppCell	facs-GAT-Fat-18m-Myeloid-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XCR1 ATP8B4 HTR7 GCNT2 RYR1 OTULINL PREX1	4.49e-06	169	173	7	7a7416fcbffcf57d19b477d9da091e04e3499524
ToppCell	facs-GAT-Fat-18m-Myeloid\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XCR1 ATP8B4 HTR7 GCNT2 RYR1 OTULINL PREX1	4.49e-06	169	173	7	0e1a99cd77edcf32bcb513abd247b2b27409ac63
ToppCell	facs-GAT-Fat-18m-Myeloid-myeloid_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XCR1 ATP8B4 HTR7 GCNT2 RYR1 OTULINL PREX1	4.49e-06	169	173	7	9bbad31ef03078f5aa456f2e1b17b49c91545ff0
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D3\|367C / Donor, Lineage, Cell class and subclass (all cells)	TPTE B3GNT7 STAT4 YPEL5 BIN2 ITM2C CTSW	4.67e-06	170	173	7	7a8b90ff37c5b3b31820924a3e7f4ce20319f896
ToppCell	Immune-dendritic_cell\|World / Lineage, Cell type, age group and donor	DENND5B XCR1 IRF8 TLR10 HMSD SLC12A3 CPVL	4.85e-06	171	173	7	6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN	4.85e-06	171	173	7	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	facs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKD2L1 CHST1 HID1 REXO2 PKD2L2 NECAB1 TMEM181	5.04e-06	172	173	7	65b8935a972bf00b7a10dc2d442128fc0ed78bcb
ToppCell	BL-critical-LOC-Lymphoid-PC\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DENND5B NLRP7 HID1 ALG9 SHCBP1 ITM2C DNAH8	5.24e-06	173	173	7	90700a876d997f7c0f7b3899dffcda7fdafee547
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	XCR1 SH2B3 IRF8 TLR10 HMSD NLRC5 CPVL	5.24e-06	173	173	7	73f858f2c45d19b9ec8d99ac02c91551790f670c
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C MYH11 ATP8B1 EBF1 RYR2 TGM2 CSMD1	5.44e-06	174	173	7	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	metastatic_Brain-Myeloid_cells-CD141+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	XCR1 IRF8 TLR10 SERPINI2 PKD2L2 NLRC5 CPVL	5.44e-06	174	173	7	5ec8a48a390379d6c422120dce46437a77da67cc
ToppCell	10x5'v1-week_14-16-Myeloid_DC-DC-tDC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	IRF8 HMSD SLC12A3 MGST2 CCR5 ITM2C OTULINL	5.86e-06	176	173	7	fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP7 SH2B3 IRF8 TLR10 SLC12A3 SNAP91 ITM2C	6.09e-06	177	173	7	8887ff6341eb070bdaa890cc2cd7745f0cf1b0af
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP7 SH2B3 IRF8 TLR10 SLC12A3 SNAP91 ITM2C	6.09e-06	177	173	7	507f06d31ab773099c9431b6f433899dc97b5566
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP8B4 IRF8 STAT4 SNAP91 BIN2 CTSW	6.20e-06	116	173	6	f7f0cd61723c94586504b656a8d4e098e98d8e23
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C MYH11 OBSCN EBF1 PREX2 RYR2 PTN	6.32e-06	178	173	7	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IRF8 STAT4 CLEC2D BIN2 OTULINL PREX1 CTSW	6.32e-06	178	173	7	f914092c20130207193f97c6044ae61a9a440a86
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IRF8 STAT4 CLEC2D BIN2 OTULINL PREX1 CTSW	6.32e-06	178	173	7	7905621f5b2aa55324c5592d1d2fef763a5fa41f
ToppCell	LPS_only-Lymphocytic_NKT-iNKT/MAIT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IRF8 STAT4 CLEC2D BIN2 OTULINL PREX1 CTSW	6.55e-06	179	173	7	de3ddc1264e43727be50d69b81cc84a3c91812a2
ToppCell	LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IRF8 STAT4 CLEC2D BIN2 OTULINL PREX1 CTSW	6.55e-06	179	173	7	def981e97e3ff9019910c9af3861ca0d08eb0d0f
ToppCell	metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HIPK4 STAT4 CLEC2D CCR5 BIN2 ITM2C CTSW	6.79e-06	180	173	7	16516dd9c78c27fc76f58d650de9851ffa0763e7
ToppCell	10x5'v1-week_17-19-Myeloid_DC-DC-tDC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	IRF8 CC2D2B SLC12A3 MGST2 CCR5 ITM2C OTULINL	7.30e-06	182	173	7	ad5c99ec62cdab347d3a03c971d981e3b924020c
ToppCell	cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATP8B4 SH2B3 IRF8 LGALS12 TLR10 OTULINL CPVL	7.57e-06	183	173	7	9840706f972387241bf1d4ba8af25efc3214a91b
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATP8B4 IRF8 STAT4 CLEC2D BIN2 OTULINL CTSW	7.57e-06	183	173	7	2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1
ToppCell	IPF-Lymphoid-ILC_A\|IPF / Disease state, Lineage and Cell class	ATP8B4 STAT4 CLEC2D PLEKHA2 BIN2 ITM2C CTSW	7.57e-06	183	173	7	49bfeaae13eb236f61a5486ee75c39789936bb8a
ToppCell	Control-APC-like\|Control / group, cell type (main and fine annotations)	ATP8B4 SH2B3 IRF8 PICALM SLC12A3 CPVL PREX1	7.57e-06	183	173	7	c313ac72cc9fa1583456d452393f61f0a4ca33a8
ToppCell	cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATP8B4 SH2B3 IRF8 LGALS12 TLR10 OTULINL CPVL	7.57e-06	183	173	7	409cb52cf4c967e52bf75a6680bcbe87f638c75d
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C EBF3 EBF1 RALGAPA2 PREX2 CC2D2B TGM2	7.57e-06	183	173	7	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 OBSCN RYR2 RYR3 ZFHX4 CSMD1 DNAH11	7.84e-06	184	173	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	10x5'-blood-Myeloid_Dendritic-DC1\|blood / Manually curated celltypes from each tissue	XCR1 IRF8 RYR1 TLR10 TTLL12 TGM2 CPVL	7.84e-06	184	173	7	09fa465d1852b9b7e0405c27d4e5de276c9ba871
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 OBSCN RYR2 RYR3 ZFHX4 CSMD1 DNAH11	7.84e-06	184	173	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 OBSCN RYR2 RYR3 ZFHX4 CSMD1 DNAH11	7.84e-06	184	173	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	XCR1 HTR7 SH2B3 IRF8 TLR10 NLRC5 CPVL	7.84e-06	184	173	7	4f4aeef3b821a003e857fe4a195124d44b2d7479
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CYP27A1 ATP10B PREX2 PTN RIN2 KIAA1755 PREX1	8.13e-06	185	173	7	b5277190866d9eb5b85eceaa5ba116ea6e6f286b
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NPL GPR155 ATP8B4 RYR1 TPCN1 TNFAIP2 CPVL	8.13e-06	185	173	7	8207f9eff113eed429e961748c6b17d672a13b33
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B GPR155 CHST1 HID1 RYR1 REXO2 ITM2C	8.13e-06	185	173	7	238938a4682b44e88a30b86b13af4feeabe9553d
ToppCell	wk_08-11-Hematologic-Myeloid-APOE+_Mac2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NPL PGA4 PGA5 CCR5 BIN2 CPVL PREX1	8.13e-06	185	173	7	8f843badc0e26cb7300c83db56c7974beb90fcf3
Drug	cis-diammineplatinum(II	RYR1 RYR2 RYR3	4.24e-07	3	172	3	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR2 RYR3	4.24e-07	3	172	3	CID002750949
Drug	8N3-cADPR	RYR1 RYR2 RYR3	4.24e-07	3	172	3	CID000127713
Drug	aminodantrolene	RYR1 RYR2 RYR3	4.24e-07	3	172	3	CID009570289
Drug	2-hydroxycarbazole	RYR1 RYR2 RYR3	4.24e-07	3	172	3	CID000093551
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR2 RYR3	4.24e-07	3	172	3	CID005748312
Drug	AC1L1IZE	ATP8A2 PGA5 RYR1 RYR2 RYR3 GBA3 ORC2 DNAH8 DNAH11	6.98e-07	131	172	9	CID000004799
Drug	PCB74	RYR1 RYR2 RYR3	1.69e-06	4	172	3	CID000036218
Drug	148504-47-6	RYR1 RYR2 RYR3	1.69e-06	4	172	3	CID006444275
Drug	SC 38249	RYR1 RYR2 RYR3	1.69e-06	4	172	3	CID000134834
Drug	AC1L1U7A	RYR1 RYR2 RYR3	1.69e-06	4	172	3	CID000035682
Drug	AC1N9ZZC	ANK3 ATP8A2 OBSCN PICALM RYR1 RYR2 RYR3 SNAP91 AQR	2.05e-06	149	172	9	CID004369374
Drug	Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A	GPLD1 IRF8 ATP10B GCNT2 ATP8B2 STAT4 NDST3 TGM2 ITM2C SERPINA7	2.54e-06	196	172	10	3849_UP
Drug	LOPAC	RYR1 RYR2 RYR3 TGM2 PI4KA	2.84e-06	30	172	5	CID000062696
Drug	FPL 64176	CACNA1C RYR1 RYR2 RYR3	4.02e-06	15	172	4	CID000003423
Drug	Cinildipine	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	4.04e-06	56	172	6	CID000002752
Drug	CNS 1145	CACNA1C RYR1 RYR2 RYR3 PKD2	4.64e-06	33	172	5	CID000190902
Drug	IHC-64	CACNA1C RYR1 RYR2 RYR3 PKD2	4.64e-06	33	172	5	CID000162753
Drug	nilvadipine	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	6.08e-06	60	172	6	CID000004494
Drug	lercanidipine	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	8.10e-06	63	172	6	CID000065866
Drug	chloro-m-cresol	RYR1 RYR2 RYR3	8.33e-06	6	172	3	CID000012008
Drug	MBED	RYR1 RYR2 RYR3	8.33e-06	6	172	3	CID000129958
Drug	AC1O528X	RYR1 RYR2 RYR3	8.33e-06	6	172	3	CID006475857
Drug	NSC114784	RYR1 RYR2 RYR3	8.33e-06	6	172	3	CID000419425
Drug	lanthanum	CACNA1C PKD2L1 RYR1 RYR2 RYR3 TPCN1 PKD2L2 PKD2	9.33e-06	136	172	8	CID000023926
Drug	gallopamil	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	1.16e-05	67	172	6	CID000001234
Drug	AC1L2AC7	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	1.38e-05	69	172	6	CID000068733
Drug	[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate	RYR1 RYR2 RYR3	1.45e-05	7	172	3	CID009547999
Drug	Azumoleno	RYR1 RYR2 RYR3	1.45e-05	7	172	3	CID000056259
Drug	Br2BAPTA	RYR1 RYR2 RYR3	1.45e-05	7	172	3	CID003081001
Drug	Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; PC3; HT_HG-U133A	TMEM120B ANK3 ATP8B1 PICALM ATP8B2 PTN TGM2 OTUB2 PI4KA	1.90e-05	196	172	9	7257_DN
Drug	CAS 298-57-7	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	1.91e-05	73	172	6	CID000002761
Drug	ethosuximide	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	2.06e-05	74	172	6	CID000003291
Drug	nisoldipine	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	2.79e-05	78	172	6	CID000004499
Drug	PCB 95	RYR1 RYR2 RYR3	4.89e-05	10	172	3	CID000038012
Drug	pimozide	CACNA1C HTR7 RYR1 RYR2 RYR3 TPCN1 PKD2	5.19e-05	127	172	7	CID000016362
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	5.67e-05	2	172	2	ctd:C005147
Drug	bilirubin glucoside	GBA3 GUSB	5.67e-05	2	172	2	CID006443775
Drug	PCB 66	RYR1 RYR2 RYR3	6.69e-05	11	172	3	CID000036185
Drug	R 478	RYR1 RYR2 RYR3	6.69e-05	11	172	3	CID000084223
Drug	8-amino-cADPR	RYR1 RYR2 RYR3	6.69e-05	11	172	3	CID003081323
Drug	tectoridin	RYR1 RYR2 GUSB	6.69e-05	11	172	3	CID005281810
Drug	manidipine	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	8.49e-05	95	172	6	CID000004008
Drug	Ryanodine	RYR1 RYR2 RYR3	8.87e-05	12	172	3	ctd:D012433
Drug	verapamil	CACNA1C MYH11 HTR7 APOA5 ATP8B1 GCNT2 SLCO1B1 RYR1 RYR2 RYR3 TPCN1 GUSB PKD2	9.45e-05	490	172	13	CID000002520
Drug	IAA-94	CACNA1C RYR1 RYR2 RYR3 PKD2	9.81e-05	61	172	5	CID000003667
Drug	nitrendipine	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	1.01e-04	98	172	6	CID000004507
Drug	isradipine	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	1.13e-04	100	172	6	CID000003784
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	DENND5B GPLD1 GCNT2 PREX2 TGM2 RIN2 ATP11A AQR	1.14e-04	193	172	8	5633_DN
Drug	dihydropyridine	CACNA1C GCNT2 RYR1 RYR2 RYR3 TPCN1 SNAP91 PKD2	1.14e-04	193	172	8	CID000104822
Drug	mibefradil	CACNA1C RYR1 RYR3 TPCN1 PKD2	1.23e-04	64	172	5	CID000060662
Drug	Lysergol [602-85-7]; Up 200; 15.8uM; MCF7; HT_HG-U133A	DENND5B ATP8A2 SMC4 PREX2 MET TGM2 ZFHX4 RIN2	1.26e-04	196	172	8	3261_UP
Drug	sulfobromophthalein	ATP8B1 CHST1 SLCO1B1 USP2 MGST2 IL5	1.33e-04	103	172	6	CID000005345
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A	GPLD1 IRF8 ATP10B ATP8B2 MET TGM2 ZFHX4 ITM2C	1.36e-04	198	172	8	4410_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A	XCR1 GCNT2 TLR8 USP2 SERPINI2 ZFHX4 RAB3GAP2 ATP11A	1.40e-04	199	172	8	6783_UP
Drug	Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	NPL TMEM120B CYP27A1 ATP10B ATP8B2 PTN ATP11A FAIM2	1.40e-04	199	172	8	1521_UP
Drug	loperamide	CACNA1C RYR1 RYR2 RYR3 TPCN1 PKD2	1.48e-04	105	172	6	CID000003954
Drug	uranium nitrate	GBA3 GUSB	1.69e-04	3	172	2	CID000027534
Drug	ethyl anthranilate	GBA3 GUSB	1.69e-04	3	172	2	CID000006877
Drug	A-1155463	MET BRAF	1.69e-04	3	172	2	ctd:C000603579
Drug	phloroglucinaldehyde	GBA3 GUSB	1.69e-04	3	172	2	CID000068099
Drug	AC1NDR9H	GBA3 GUSB	1.69e-04	3	172	2	CID000020688
Drug	1,1'-diheptyl-4,4'-bipyridinium	RYR1 RYR3	1.69e-04	3	172	2	CID000080262
Drug	virgaureasaponin	GBA3 GUSB	1.69e-04	3	172	2	CID006324777
Drug	aluminum hydroxyphosphate	CPVL IL5	1.69e-04	3	172	2	CID006336693
Drug	flubendiamide	RYR1 RYR3	1.69e-04	3	172	2	CID011193251
Drug	1,2-dichlorohexafluorocyclobutane	HTR7 RYR1 RYR2 RYR3	1.71e-04	37	172	4	CID000009643
Drug	Gvapspat amide	RYR1 RYR2 RYR3	1.80e-04	15	172	3	CID000125015
Drug	CTK2H7103	NPL CYP27A1 ATP8B1 GBA3 REXO2 OTUB2 GUSB TNFAIP2	1.96e-04	209	172	8	CID005462309
Drug	p904	NPL B3GNT7 CHST1 NDST3 GBA3 GUSB ALG9 TNFAIP2 NUP93	2.04e-04	267	172	9	CID000065150
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2 RYR3	1.85e-07	3	169	3	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2 RYR3	1.85e-07	3	169	3	DOID:8545 (implicated_via_orthology)
Disease	polycystic kidney disease 2 (implicated_via_orthology)	PKD2L1 PKD2L2 PKD2	1.85e-07	3	169	3	DOID:0110859 (implicated_via_orthology)
Disease	Statin causing adverse effect in therapeutic use	SLCO1B1 RYR1	3.26e-05	2	169	2	cv:C0570410
Disease	Statin-induced myopathy	SLCO1B1 RYR1	3.26e-05	2	169	2	cv:CN181199
Disease	Hyperlipoproteinemia Type IV	APOA5 LIPI	3.26e-05	2	169	2	C0020480
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD2L1 PKD2L2 PKD2	6.41e-05	14	169	3	DOID:898 (implicated_via_orthology)
Disease	Long Qt Syndrome 2	ALG10B ALG10	9.75e-05	3	169	2	C3150943
Disease	overall survival, pancreatic carcinoma	CACNA1C SLITRK1 PREX2 SBF2	1.80e-04	49	169	4	EFO_0000638, EFO_0002618
Disease	X-11372 measurement	ATP8B4 SLCO1B1	1.94e-04	4	169	2	EFO_0800694
Disease	Gilles de la Tourette syndrome (implicated_via_orthology)	SLITRK1 MET	1.94e-04	4	169	2	DOID:11119 (implicated_via_orthology)
Disease	monocyte count	SH2B3 IRF8 PKD2L1 B3GNT7 EBF1 GCNT2 SLCO1B1 TLR8 PREX2 RYR1 TTLL12 GUSB PI4KA NLRC5 PLEKHA2 ITM2C PREX1 CTSW RAPGEFL1	2.13e-04	1320	169	19	EFO_0005091
Disease	resting heart rate	CACNA1C MYH11 B3GNT7 MET KIAA1755 CSMD1	2.26e-04	149	169	6	EFO_0004351
Disease	1-palmitoleoyl-GPC (16:1) measurement	PKD2L1 SLCO1B1	3.22e-04	5	169	2	EFO_0800231
Disease	myeloid white cell count	TMEM120B SH2B3 EBF1 GCNT2 PREX2 TTLL12 MET TGM2 SNX32 SBF2 NLRC5 KIAA1755 ITM2C PREX1 RAPGEFL1	3.40e-04	937	169	15	EFO_0007988
Disease	psychosis predisposition measurement	CACNA1C TMC7 CSMD1	4.36e-04	26	169	3	EFO_0008337
Disease	tetradecadienedioate (C14:2-DC) measurement	PKD2L1 SLCO1B1	4.82e-04	6	169	2	EFO_0800585
Disease	nonsyndromic deafness (implicated_via_orthology)	ALG10B ALG10	4.82e-04	6	169	2	DOID:0050563 (implicated_via_orthology)
Disease	pneumonia, COVID-19	XCR1 TMEM120B SH3BGRL PPP2R5E CSMD1	4.95e-04	113	169	5	EFO_0003106, MONDO_0100096
Disease	susceptibility to hepatitis B infection measurement	CACNA1C GMDS CSMD1 PREX1	5.05e-04	64	169	4	EFO_0008405
Disease	chronic obstructive pulmonary disease (biomarker_via_orthology)	STAT1 STAT4 FAIM2	5.44e-04	28	169	3	DOID:3083 (biomarker_via_orthology)
Disease	level of oxylipin in blood plasma	TGM2 KIAA1755	6.72e-04	7	169	2	OBA_2050338
Disease	X-16935 measurement	ATP8B4 SLCO1B1	6.72e-04	7	169	2	EFO_0800763
Disease	eating disorder	ATP8A2 B3GNT7 CSMD1	8.10e-04	32	169	3	EFO_0005203
Disease	carnitine measurement	ANK3 PKD2L1 GBA3 SERPINA7	9.67e-04	76	169	4	EFO_0010469
Disease	monocyte percentage of leukocytes	SH2B3 IRF8 B3GNT7 EBF1 GCNT2 SLCO1B1 PI4KA KIAA1755 PLEKHA2 DNAJC1 PPP2R3C RAPGEFL1	1.08e-03	731	169	12	EFO_0007989
Disease	Mental deterioration	CACNA1C PICALM	1.14e-03	9	169	2	C0234985
Disease	Mild cognitive disorder	CACNA1C PICALM	1.14e-03	9	169	2	C1270972
Disease	Polycystic Kidney, Autosomal Dominant	ALG9 PKD2	1.14e-03	9	169	2	C0085413
Disease	Behcet's disease (is_implicated_in)	IRF8 STAT4 CCR5	1.15e-03	36	169	3	DOID:13241 (is_implicated_in)
Disease	leptin measurement	ALG10B ALG10 CPVL DNAH8	1.23e-03	81	169	4	EFO_0005000
Disease	basophil percentage of granulocytes	ATP8B4 LGALS12 RYR1 REXO2	1.34e-03	83	169	4	EFO_0007995
Disease	Malignant neoplasm of breast	TPTE CATSPERE UBR4 OBSCN IRF8 ATP8B1 SLCO1B1 PKDREJ STAT1 STAT4 TGM2 BRAF SNX32 OSBPL11 NLRC5	1.36e-03	1074	169	15	C0006142
Disease	metabolite measurement	CCDC121 ATP8B4 ANK3 CYP27A1 PKD2L1 SLC7A6 SLCO1B1 GBA3 OTULINL CSMD1	1.52e-03	560	169	10	EFO_0004725
Disease	event free survival time, type 1 diabetes mellitus, autoantibody measurement	SH2B3 TTC34	2.07e-03	12	169	2	EFO_0000482, EFO_0004866, MONDO_0005147
Disease	Charcot-Marie-Tooth disease type 4	FIG4 SBF2	2.44e-03	13	169	2	cv:C4082197
Disease	RS-10-hydroxywarfarin measurement	PREX2 GBA3 NECAB1 ITM2C	2.47e-03	98	169	4	EFO_0803330
Disease	response to antineoplastic agent	UBR4 SLCO1B1 RYR2 PPP2R5E	2.56e-03	99	169	4	GO_0097327
Disease	Impaired cognition	CACNA1C PICALM	2.84e-03	14	169	2	C0338656
Disease	cerebral atherosclerosis	WASF3 RIN2	2.84e-03	14	169	2	EFO_1000860
Disease	basophil percentage of leukocytes	ATP8B4 PKD2L1 LGALS12 RYR1 REXO2 BIN2	2.85e-03	243	169	6	EFO_0007992
Disease	lifestyle measurement, depressive symptom measurement	ATP8B1 EBF1 NDST3 SNAP91	3.17e-03	105	169	4	EFO_0007006, EFO_0010724
Disease	Lymphoma, Follicular, Grade 2	ATP6V1B2 EBF1	3.26e-03	15	169	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	ATP6V1B2 EBF1	3.26e-03	15	169	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	ATP6V1B2 EBF1	3.26e-03	15	169	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	ATP6V1B2 EBF1	3.26e-03	15	169	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	ATP6V1B2 EBF1	3.26e-03	15	169	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	ATP6V1B2 EBF1	3.26e-03	15	169	2	C0079758
Disease	Hypertriglyceridemia	APOA5 LIPI	3.26e-03	15	169	2	C0020557
Disease	cholesteryl ester 16:1 measurement	APOA5 PKD2L1	3.71e-03	16	169	2	EFO_0010342
Disease	Ciliopathies	NPHP1 PKD2 DNAH8 DNAH11	3.74e-03	110	169	4	C4277690
Disease	Autistic Disorder	GPR155 CACNA1C TAF1C MET TBR1 IL5	4.04e-03	261	169	6	C0004352
Disease	antisaccade response measurement	B3GNT7 GBA3 CSMD1	4.10e-03	56	169	3	EFO_0006874
Disease	Benign neoplasm of stomach	MET BRAF	4.19e-03	17	169	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	MET BRAF	4.19e-03	17	169	2	C0496905
Disease	extrahepatic cholestasis (biomarker_via_orthology)	CYP27A1 PTN	4.19e-03	17	169	2	DOID:13619 (biomarker_via_orthology)
Disease	Carcinoma in situ of stomach	MET BRAF	4.19e-03	17	169	2	C0154060
Disease	Vascular Diseases	SLC12A3 PKD2	4.19e-03	17	169	2	C0042373
Disease	Hypertrophic Cardiomyopathy	CACNA1C OBSCN RYR2	4.30e-03	57	169	3	C0007194
Disease	Antihypertensive use measurement	CACNA1C MYH11 EBF1 SBF2 GMDS PREX1	4.34e-03	265	169	6	EFO_0009927
Disease	severe acute respiratory syndrome, COVID-19	XCR1 USP9X ATP8A2 LGALS12 PREX2 OSBPL11 ATP11A CSMD1	4.38e-03	447	169	8	EFO_0000694, MONDO_0100096
Disease	respiratory syncytial virus infectious disease (is_marker_for)	TLR8 CCR5	4.70e-03	18	169	2	DOID:1273 (is_marker_for)
Disease	Sjogren's syndrome (is_implicated_in)	STAT4 CCR5	4.70e-03	18	169	2	DOID:12894 (is_implicated_in)
Disease	asthma (biomarker_via_orthology)	STAT1 STAT4 IL5	4.74e-03	59	169	3	DOID:2841 (biomarker_via_orthology)
Disease	Schizophrenia	CACNA1C KREMEN1 ANK3 HTR7 CHRM4 NDST3 MET TGM2 PI4KA CCR5 PIP4K2C CSMD1	5.04e-03	883	169	12	C0036341
Disease	rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement	SH2B3 TTC34 STAT4	5.70e-03	63	169	3	EFO_0000685, EFO_0007791, EFO_0009459

Protein segments in the cluster

Peptide	Gene	Start	Entry
RQLQTVNNYFLFSLA	CHRM4	61	P08173
LQLVYEFFIRFLESQ	PPP2R5E	151	Q16537
VNYDQLDLLFVSKFF	BRAF	281	P15056
YRVRHFFNNFTQLIT	CATSPERE	106	Q5SY80
QFAYFQTALNDLAEL	CSMD1	1666	Q96PZ7
NSLSNYQFLFQDLAI	ATP13A4	926	Q4VNC1
YLINGFLNFNVAFAL	ALG9	306	Q9H6U8
YIFNLRDLSNVFQGI	DNAH11	2706	Q96DT5
QAFRQDTYLQIAAFT	APOA5	286	Q6Q788
LRFVNLLFSVGNFYL	ALG10B	96	Q5I7T1
IFQKLNIFDQSFYDL	ANGPTL3	71	Q9Y5C1
LYIFARVSLFQNCFE	AQR	1301	O60306
ERFIQYLASRNTLFN	SNAP91	91	O60641
INLFEQFQRVANAYF	ATP8B4	46	Q8TF62
SALSQYFFVREIFEQ	CCDC180	626	Q9P1Z9
YNIVLLLNTFQEFFG	CCR5	251	P51681
YVTIFQNISNLRDVF	BIN2	206	Q9UBW5
YFRLEQLQDEFNFVS	CC2D2B	706	Q6DHV5
LVQAENRFFLEYLTN	CCDC121	31	Q6ZUS5
FDLVEEVQLNFYQFL	DNAJC1	56	Q96KC8
RFLYEQIRRAANAFF	ATP8A2	86	Q9NTI2
NLFEQFKRAANLYFL	ATP8B1	111	O43520
YTLFTFLPRNLFEQF	ATP10B	76	O94823
QGLIFQITAFQEDFY	ADAMTS15	51	Q8TE58
QFQEVANTYFLFLLI	ATP8B2	71	P98198
LYFQVLFLTAQFEAA	NUP93	461	Q8N1F7
NDRLGLYTFVNLANF	NDST3	526	O95803
YQQQRRKFAAAFLAF	PTN	6	P21246
KFYIIQLLQDSNRFF	PARP3	81	Q9Y6F1
VLQNFREQNVFYDFK	KBTBD3	41	Q8NAB2
LNVFSLNYFFRAIQE	PPP2R3C	361	Q969Q6
VFIRQYFTVFDRANN	PGA5	366	P0DJD9
YLENLAIQRNASAFF	ANKAR	21	Q7Z5J8
LTLFAFNNRFQQYLI	ANKAR	1151	Q7Z5J8
FNNRFQQYLILESGI	ANKAR	1156	Q7Z5J8
RNFFNAFYSVVELVE	OTUB2	96	Q96DC9
VQFCYFQDLQAARDF	RAB3GAP2	6	Q9H2M9
IYIFTFFLQLFGTNR	FAIM2	301	Q9BWQ8
IYNLLSRRFQAAFQN	NMUR2	326	Q9GZQ4
VNFREAYNLFAVNGI	GMDS	191	O60547
YLVFELLEQNLFEFQ	HIPK4	86	Q8NE63
RAVFLRLFAQLFQGY	SBF2	356	Q86WG5
GRLYVELQFFCAVFN	GPR155	686	Q7Z3F1
ENFFLQAAAQYRRGL	KIAA1755	886	Q5JYT7
YVALTRDFANFVLQD	GCNT2	266	Q8N0V5
RVRLYFFISNEGNQN	INHBB	156	P09529
AVQFQEYVFLQFLGL	GDF3	21	Q9NR23
FLARLQQQAYSVFVV	ATXN3L	151	Q9H3M9
ARDLYSALIQFFQIF	CPVL	176	Q9H3G5
IRAYEFAVDQLAFQS	FBXW8	556	Q8N3Y1
VFDTSQFFRELQQFY	IRF8	321	Q02556
FYPQRFFEVLLLFQE	LGALS12	281	Q96DT0
VFAFDVNRNRVLNSY	MMP21	471	Q8N119
SFDFLAEKLQFYQRQ	DNAH8	2766	Q96JB1
YNEIQNGNASLFFRR	HHLA2	96	Q9UM44
YQREFDFFNKITNVS	PI4KA	1731	P42356
DESTLAFQQARYNFI	PI4KA	1926	P42356
LDFVILYFFSDRINQ	KREMEN1	296	Q96MU8
FIFYENFIALENSLK	RALGAPA2	56	Q2PPJ7
QLRHLYFLFLNNNFI	LRRC70	106	Q7Z2Q7
NCFQALFLFEFRQLN	NLRC5	251	Q86WI3
DNYDALRSVLFQIFS	OTULINL	136	Q9NUU6
VSNQNIQYFLDRFYL	PDK2	146	Q15119
VFIRQYFTVFDRANN	PGA3	366	P0DJD8
RYFFLAQLARDNFFR	ITM2C	81	Q9NQX7
YFFLRNLSFLEIGFN	OR10A4	61	Q9H209
TLQQAEYEFLSFVRQ	REXO2	116	Q9Y3B8
FIKNQAAFEQYLEFL	OBSCN	5771	Q5VST9
ERTFSAYQRQQDFFV	DAAM1	646	Q9Y4D1
RVNQFLDYLQEFLGV	IL5	111	P05113
QAYFVSLFNRFDCFV	CACNA1C	581	Q13936
VRNDIDFFRNIKFNY	BTAF1	1386	O14981
EYFRQTFQELFKAIQ	GBA3	391	Q9H227
VRLGRLFLYSFNDNN	DPH7	61	Q9BTV6
LRIFQNVDLSSNFYF	FIG4	151	Q92562
TRDEFAQLFQYKAVF	ATG9A	461	Q7Z3C6
FDFFNYAGLQRSVLL	GUSB	206	P08236
LRFFFQLFVQGYALQ	CYP27A1	66	Q02318
AFKLFQIQFNRSYLS	CTSW	41	P56202
YQLNVQLREVFANRF	DENND5B	496	Q6ZUT9
QQLVFNFYSFKENRL	ANK3	1381	Q12955
NFFHFVLALYDRQGQ	EBF1	66	Q9UH73
LYISQANFILAYQFR	FBXW4	131	P57775
NILLFYFDNILNSFI	HMSD	116	A8MTL9
NFFHFVLALYDRQGQ	EBF3	66	Q9H4W6
FQVLEPQFRQFLFYR	B3GNT7	101	Q8NFL0
ARFTSQFLKLDYFQN	PRAMEF8	256	Q5VWM4
YTLRFLALFLAFAIN	RYR1	4561	P21817
QTFLELAESVLNYFQ	RYR2	4116	Q92736
SQLLEEGNQFRANYF	NPHP1	336	O15259
YFFLRNLSFLEIGFN	OR10A5	61	Q9H207
QYRFFVLNNEAGLLE	OSBPL11	76	Q9BXB4
VFIRQYFTVFDRANN	PGA4	366	P0DJD7
EQYAKRFLDFITNIF	PIP4K2C	406	Q8TBX8
TINDQDFFLYTARQA	MAP3K4	276	Q9Y6R4
FERVFRAQQNCVEFY	MGST2	46	Q99735
LSFQDFYQQCREAFL	ORC2	511	Q13416
LSEIYQFLQSRFPFF	FOXF1	71	Q12946
NNFIYFLTVQRETLD	MET	256	P08581
LALNYQFCIQRFINF	NPL	241	Q9BXD5
NLEFESQSFLYRQVR	PUSL1	221	Q8N0Z8
CFVINALSQRYFLQA	PLEKHA2	81	Q9HB19
YLEFLQKFERNFIAQ	ATP6V1B2	451	P21281
NVLFNVSNRFSEYLL	USP9X	2091	Q93008
RIITVNFAINDLYFF	RGSL1	871	A5PLK6
NYLFQFFVPADQALR	PSAPL1	226	Q6NUJ1
RKFVSLIFSILYFQN	SLC35B4	276	Q969S0
DQYSRFSLENNFLLQ	STAT1	66	P42224
SALQYEKFLNEFFLN	CARS1	451	P49589
FLQDQFVSNYAKARF	TBR1	431	Q16650
QYLNFANNILTDELF	TLR10	351	Q9BXR5
IYQKFRNQFLAFSIF	TMEM120B	211	A0PK00
ILAQFYNDFVNISSI	LIPI	386	Q6XZB0
FQLSAAGDVFYQQLR	TAF1C	586	Q15572
FFYDVRLAQRAIQAA	PKDREJ	2071	Q9NTG1
FLLEVFNNIIQYQFD	HID1	531	Q8IV36
IQERAFFLFDNLLVY	PREX1	286	Q8TCU6
AFFEARENNAVYAFL	SH3BGRL	81	O75368
FQQFLTALFYALEKE	NLRP7	471	Q8WX94
GFVREQFCDYLFQQA	PELO	211	Q9BRX2
FQTNQLLFYERFRAY	SHCBP1	71	Q8NEM2
IDYVFSQFATLNRNL	MROH2B	396	Q7Z745
FQQLFRYLVLDIADN	STYX	76	Q8WUJ0
TRKFYFFVAIQVLNL	SLCO1B1	531	Q9Y6L6
NSLINPFIYAFFNRD	HTR7	376	P34969
LRFVNLLFSVGNFYL	ALG10	96	Q5BKT4
RFRLSYDIVAFAQNA	CHST1	361	O43916
AQVESFQELNFLLRY	CLEC2D	111	Q9UHP7
FEQFRRVANFYFLII	ATP11A	66	P98196
EQFRRVANFYFLIIF	ATP11B	61	Q9Y2G3
KNLFEQFRRIANFYF	ATP11C	61	Q8NB49
QFRRIANFYFLIIFL	ATP11C	66	Q8NB49
FQEFRQRYEILAANA	MYH11	721	P35749
ERFIQYLASRNTLFN	PICALM	91	Q13492
DQNSNLLIEYFRNEF	TGM2	306	P21980
ARFTSQFLKLDYFQN	PRAMEF7	256	Q5VXH5
LFSQQHFLRQQEFLY	TNRC18	901	O15417
YNFTLFLQTLFRTQI	XCR1	241	P46094
DFQNYLRVAFQEVNS	RIN2	786	Q8WYP3
FKLFQNFSNLEIIYL	TLR8	411	Q9NR97
FVERRQQYFSDLFNI	TPTE	146	P56180
QQYFSDLFNILDTAI	TPTE	151	P56180
TRFTDYQLRVLQDFF	ZFHX4	2186	Q86UP3
YQLRVLQDFFDTNAY	ZFHX4	2191	Q86UP3
AFLRSYQRAFNEFLE	TNFAIP2	396	Q03169
RAFLFNKVVNLQYSE	YPEL5	41	P62699
ENNIEIVTRFYLAFQ	WASHC5	86	Q12768
TRLFPNEFANFYNAV	SLITRK1	71	Q96PX8
LYLRFGAQVLQDNFV	TMEM181	511	Q9P2C4
LARNFYNLRFLALFV	RYR3	4406	Q15413
YNLRFLALFVAFAIN	RYR3	4411	Q15413
FLIYNLFKNSFVVER	STAT4	306	Q14765
NADFAFNLYRRFTVE	SERPINA7	46	P05543
IFGELFNEANNFYIR	WASF3	51	Q9UPY6
QSVQLFILYFFNLAV	TMEM79	286	Q9BSE2
DVLSQFEFNFNYLAR	GPLD1	166	P80108
FHQVLIRYFQRQTSF	TTC41P	701	Q6P2S7
QAFYFALRDTLVADN	SMC4	706	Q9NTJ3
GFFSYRADIFVQNLV	SLC12A3	316	P55017
ELVSLQFTDLFQRYF	SH2B3	61	Q9UQQ2
QEFTFNLANALYLQE	SERPINI2	101	O75830
QERVFFLFDNLLVYC	PREX2	261	Q70Z35
IFIDFSLYNANVNLF	PKD2L2	231	Q9NZM6
FSVYNANINLFCVVR	PKD2	426	Q13563
FNLRTELPQFVSYFQ	TTLL12	391	Q14166
GLQFLFEYFSETQRN	TRBV5-1	61	A0A578
VFIDFSVYNANINLF	PKD2L1	301	Q9P0L9
YLNNFDNILNSFVTL	TPCN1	626	Q9ULQ1
LIVEDVFQLINYFSF	SLC7A6	381	Q92536
IFVSRYLYNLNNQIF	WASHC4	791	Q2M389
NVLAAFSQYFRSLFQ	ZBTB49	41	Q6ZSB9
TISFNYNDEIANRFL	VWA3B	631	Q502W6
FQVIDNQNLLFELSY	RAPGEFL1	641	Q9UHV5
VGYNQQDAQEFLRFL	USP2	351	O75604
NFFVFLEYGQDLSVR	SNX32	156	Q86XE0
FLRYINRFQDAVLAN	UBR4	266	Q5T4S7
TNFLDGIVDFFRQYV	TMEM119	81	Q4V9L6
ALLQLRRGFFYDANQ	TTC34	91	A8MYJ7
QSYFSFLRFLVLLNL	TMC7	161	Q7Z402
YQEASNLEQFVTRFL	NECAB1	121	Q8N987